Company Filing History:
2 out of 21 
1 out of 1 
1 out of 75 
Years Active: 2021-2025
Title: The Innovations of Felix Lorenz: Advancements in Immunotherapy
Introduction: Felix Lorenz is a notable inventor based in Berlin, Germany, with a focus on immunotherapy and T cell therapies. His remarkable work has contributed significantly to the field of medicine, particularly in the development of methods that enhance T cell functionality and specificity against various diseases.
Latest Patents: Lorenz holds two patents, with his latest invention being a method for detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors through the use of an MHC cell library. This invention aims to improve adoptive T cell therapy and T cell receptor (TCR) gene therapy. It encompasses a detailed methodology for formulating nucleic acids that encode TCR alpha and beta chain constructs specific to antigens presented on major histocompatibility complex (MHC). By utilizing artificial antigen-presenting cells from a donor, this method holds promise for targeting cancers, viral infections, and autoimmune diseases. The findings also include partnerships of TCR constructs with immunogenic epitopes related to human papillomavirus (HPV) and human cytomegalovirus (CMV), showing potential applications in developing vaccine formulations.
Career Highlights: Lorenz has contributed his expertise to significant research institutions, such as the Max Delbrück Center for Molecular Medicine and the Helmholtz Association, as well as the German Research Center for Environmental Health. His role in these prestigious organizations has helped advance his innovative research, which intersects crucial immunological concepts with therapeutic applications.
Collaborations: Throughout his career, Felix Lorenz has collaborated with prominent colleagues, including Wolfgang Uckert and Christian Ellinger. These partnerships have facilitated the exchange of ideas and the development of groundbreaking methodologies, further enriching the field of immunotherapy.
Conclusion: Felix Lorenz stands out as a significant inventor in the realm of immunotherapy, with two patents that reflect his commitment to advancing medical science. His innovative methods have the potential to transform treatments for serious illnesses, showcasing the importance of continued research and collaboration within this vital area of healthcare.